Position in ROIV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,241,789
-$2,239,315 QoQ
Shares Held
148,115
-70.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#138
of 494 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2023CallValue
$3,285,999
CallShares
325,992
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. ROIV ranks #39 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
659,279 | $123,469,771 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
1,417,916 | $112,426,559 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
889,298 | $109,010,148 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
697,692 | $42,112,689 | |
| 5 | MRNA |
Moderna, Inc.
|
560,819 | $39,274,154 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
276,455 | $31,701,094 | |
| 7 | LBRX |
Lb Pharmaceuticals Inc
|
863,947 | $28,039,399 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
80,846 | $27,066,432 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,241,789 | 148,115 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $7,481,104 | 494,455 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,305,809 | 115,866 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $11,540,000 | 1,000,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,570,000 | 1,000,000 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $3,298,595 | 282,414 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,285,999 | 325,992 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $2,405,820 | 325,992 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $4,144,696 | 561,612 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,348,712 | 168,800 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||